Semaglutide symptoms on day 1: what actually happens when you take your first dose

Step 1: the first injection and the hours immediately after

You administer the pen into your abdomen, thigh or upper arm, rotating the site each week. The injection itself is brief. For many people the next few hours pass without incident. Because 0.25 mg is the lowest available strength of Wegovy, the receptor signal reaching your gut and brain is gentle.

Nausea is the most commonly reported early symptom, but at this dose it is usually described as a background queasiness rather than acute sickness. Some people notice it within two to three hours of injecting; others not until later that evening. Eating a small, low-fat meal before or shortly after the injection can reduce the likelihood of nausea, a practical point the NHS semaglutide medicines page confirms.

Fatigue or a mild headache occasionally accompany the first dose, probably reflecting the same GI-motility slowing that makes nausea more likely. These are not alarming signals. They are the system recalibrating. Drink water steadily through the day; dehydration sharpens almost every GI symptom.

If you ordered through a GPhC-registered service, your pen will have arrived tracked in plain packaging (nothing on the outside identifying the contents) which matters to a lot of people who value discretion. Keep it refrigerated at 2–8°C once it arrives, in line with the Patient Information Leaflet.

Step 2: the rest of day 1 and the first night

Appetite suppression, when it arrives at this dose, is subtle. Some patients describe picking at their usual evening meal and feeling satisfied earlier than normal. Others notice no difference at all on day one, which is also completely within the range of normal.

GLP-1 receptor agonists like semaglutide slow gastric emptying, food moves through the stomach more slowly, which is part of why appetite falls and nausea can arise. At 0.25 mg this mechanism is active but mild. The semaglutide overview on this site covers the mechanism in more depth if you want the fuller picture.

Sleep is rarely disturbed after the first dose. A small proportion of people report reflux or burping in the evening if they ate a large or fatty meal; keeping dinner lighter on injection day is a common piece of practical advice from prescribers.

If nausea is present at bedtime, it generally eases overnight as absorption levels out. Lying flat can worsen reflux, so propping yourself slightly can help.

Step 3: waking up on day 2 and knowing when to act

For many people, the morning after the first dose brings the clearest signal that something is different: appetite at breakfast may be noticeably lower than usual. This is one of the most-reported day-2 experiences among people starting Wegovy, and it is generally welcome.

Any nausea from the previous day has usually settled by morning. If it has not, or if it has worsened, that warrants a message to your prescribing team. Vomiting that prevents you keeping fluids down, or severe stomach pain that radiates to your back, are symptoms requiring prompt medical attention, and our full guide to what are the symptoms of Wegovy covers these in detail alongside the Patient Information Leaflet and the detailed guide to symptoms of taking Wegovy.

The MHRA issued specific guidance in January 2026 highlighting acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines, characterised by severe, persistent abdominal pain sometimes reaching the back. Seek urgent help if that pattern develops; do not wait and see. You can also report unexpected effects directly through the Yellow Card scheme.

For questions about what to expect as doses increase over coming months, our guide to Wegovy symptoms across the full titration schedule is worth reading before your next dose review. And if you are weighing up what Wegovy treatment costs as a private patient, the Wegovy price page explains what a legitimate private prescription typically includes.

Step 4: the pattern from week 2 onwards

After the first week at 0.25 mg, most people find their body has largely adapted. The GI symptoms that appeared on or after day one have usually settled, appetite suppression may be a little more consistent, and the second injection often feels unremarkable by comparison.

The next clinical checkpoint is the dose increase, typically after four weeks, reviewed by your prescriber. That transition to 0.5 mg can bring a brief reappearance of the day-1 pattern: mild nausea for a few days, then adaptation. This cycle tends to repeat, at diminishing intensity, with each step up through the schedule.

People sometimes ask whether symptoms stopping early means the medicine has stopped working. They do not correlate directly. Side effects settling is normal and expected; it does not signal treatment failure. If you have concerns at any point in the process, the guide to symptoms after stopping Wegovy covers what happens at the other end, and our support team is reachable seven days a week.

Semaglutide is a prescription-only medicine. Everything described here reflects the clinical trial data and NHS guidance for the licensed Wegovy formulation, your own experience may differ, and any decision about starting, adjusting or stopping treatment belongs with a qualified prescriber who knows your full health history.